ERIN MINHONDO: Open Payments
NPI 1932881406 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 22 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $133 |
| ABBVIE INC. | 2 | $49 |
| Novo Nordisk Inc | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: MOUNJARO, JARDIANCE, Wegovy, LINZESS, VRAYLAR, Prolastin-C Liquid, Fluad, TRELEGY ELLIPTA.
Industry payments across UT — which companies pay providers there.
